institutional investors of Kyverna Therapeutics, Inc. (NASDAQ:KYTX) must be disappointed after last week's 18% drop Institutions' substantial holdings in Kyverna Therapeutics implies that they have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback